Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction

Kosiborod, Mikhail; S. Jhund, Pardeep; F. Docherty, Kieran; Díez, Mirta; C. Petrie, Mark; Verma, Subodh; Carlos Nicolau, José; Merkely, Béla; Kitakaze, Masafumi; L. DeMets, David; E. Inzucchi, Silvio; Køber, Lars; A. Martínez, Felipe; Ponikowski, Piotr; S. Sabatine, Marc; D. Solomon, Scott; Bengtsson, Olof; Lindholm, Daniel; Niklasson, Anna; Sjöstrand, Mikaela; Maria Langkilde, Anna; J.V. McMurray, John

doi:10.1161/circulationaha.119.044138

Public

Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction

Published in Circulation • Nov 17, 2019

Authors:

Mikhail Kosiborod

Pardeep S. Jhund

Kieran F. Docherty

Abstract

Background: Goals of management in patients with heart failure and reduced ejection fraction include reducing death and hospitalizations, and improving health status (symptoms, physical function, and quality of life). In the DAPA-HF trial (Dapagliflozin and Prevention of Adverse-Outcomes in Heart Fa...

Subject

Medicine

Ejection fraction

Heart failure

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!